Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists

Transplant Proc. 2002 Dec;34(8):3191-2. doi: 10.1016/s0041-1345(02)03673-4.

Authors

V Singh¹, K Sud, B R Mittal, H S Kohli, K L Gupta, V Sakhuja

Affiliation

¹ Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

PMID: 12493416
DOI: 10.1016/s0041-1345(02)03673-4

No abstract available

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / adverse effects
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Azathioprine / adverse effects
Azathioprine / therapeutic use
Blood Pressure / physiology
Creatinine / blood
Cyclosporine / adverse effects
Cyclosporine / therapeutic use
Erythrocyte Count
Female
Graft Rejection / epidemiology
Hematocrit
Hemoglobins / analysis
Humans
Kidney Transplantation / adverse effects*
Kidney Transplantation / physiology
Male
Polycythemia / drug therapy
Polycythemia / epidemiology*
Postoperative Complications / drug therapy
Postoperative Complications / epidemiology*
Prospective Studies
Renal Artery Obstruction / epidemiology
Retrospective Studies
Risk Factors
Smoking

Substances

Angiotensin-Converting Enzyme Inhibitors
Hemoglobins
Cyclosporine
Creatinine
Azathioprine